netFormulary
 Report : A-Z HCD items in Formulary 23/05/2018 11:49:21
[Back]
 
Section Status HCD Name
05.03.01 Restricted Use Cancer Drugs Fund Abacavir Ziagen
05.03.01 Restricted Use Cancer Drugs Fund Abacavir and Lamivudine and Zidovudine Trizivir
10.01.03 Restricted Use Cancer Drugs Fund Abatacept Orencia
01.05.03 Restricted Use Cancer Drugs Fund Adalimumab Humira
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab MabCampath
10.01.03 Restricted Use Cancer Drugs Fund Baricitinib Olumiant
10.03.01 Formulary Cancer Drugs Fund Collagenase clostridium histolyticum  Xiapex
13.05.03 Restricted Use Cancer Drugs Fund Dupilumab Dupixent
08.03.04.01 Restricted Use Cancer Drugs Fund Fulvestrant Faslodex
08.01.05 Restricted Use Cancer Drugs Fund Ibrutinib Imbruvica
20.01 Restricted Use Cancer Drugs Fund Idelalisib 100mg and 150mg tablets Zydelig
24.01 Formulary Cancer Drugs Fund Immunoglobulins 
03.04.02 Restricted Use Cancer Drugs Fund Mepolizumab Nucala
01.09.01 Formulary Cancer Drugs Fund Obeticholic acid  Ocaliva
03.04.02 Restricted Use Cancer Drugs Fund Omalizumab Xolair
24.16 Formulary Cancer Drugs Fund Palivizumab Neonatal
08.01.05 Restricted Use Cancer Drugs Fund Panitumumab 
24.16 Formulary Cancer Drugs Fund Poractant alfa (Curosurf) Neonatal
03.04.02 Restricted Use Cancer Drugs Fund Reslizumab  Cinqaero
03.03.03 Formulary Cancer Drugs Fund Roflumilast Daxas
10.01.03 Restricted Use Cancer Drugs Fund Sarilumab  
10.01.03 Restricted Use Cancer Drugs Fund Tofacitinib Xeljanz
08.01.05 Restricted Use Cancer Drugs Fund Trastuzumab Herceptin
08.01.05 Restricted Use Cancer Drugs Fund Trastuzumab emtansine Kadcyla
13.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara
Harrogate & Rural District Formulary